课题基金 / 基金详情

Xenoreactive Immune Response Attenuation Using Allogeneic Recellularized Tissue Engineered Heart Valve

Xenoreactive Immune Response Attenuation Using Allogeneic Recellularized Tissue Engineered Heart Valve
使用同种异体再细胞化组织工程心脏瓣膜减弱异种反应免疫反应
批准号：
475735
负责人：
Kang Ji Hoon
金额：
$7.65万
依托单位：
University of Alberta
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-11-01 至 2025-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=475735&lang=en
关键词：
Cardiac Surgery Immune System Immunology Large Animal Trial Mesenchymal Stem Cell Recellularization Tissue Engineering Valve Replacement Valvular Heart Disease Xenotransplantation

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Heart valve replacement surgery is one of the most common operations performed by cardiac surgeons. There are only two main valve options offered to patients today: mechanical and bioprosthetic valves, both options have significant limitations. Mechanical
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金